Drug Profile
Agkistrodon acutus haemocoagulase
Latest Information Update: 30 Jul 2015
Price :
$50
*
At a glance
- Originator China Nuokang Bio-Pharmaceutical
- Class Coagulants; Crotalid venoms
- Mechanism of Action Fibrinogen stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Blood coagulation disorders
Most Recent Events
- 30 Jul 2015 No recent reports on development identified - Phase-II for Coagulation disorders in China (unspecified route)
- 30 Jun 2011 Phase-II clinical trials in Coagulation disorders in China (unspecified route)
- 31 Dec 2010 Phase-I clinical trials in Coagulation disorders in China (unspecified route)